ADAGIO MEDICAL Investor Presentation | June 2024 1 DISCLAIMER This investor presentation is for informational purposes only to assist interested parties in making their.
Few people in the UK with early stage Alzheimer s disease are likely to be suitable for the latest drugs that aim to halt progress of the condition, yet many are nevertheless likely to be referred for these treatments, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.
Antidepressants save lives. They are an effective treatment for moderate and severe depression and can be of incredible benefit for people suffering other crippling mental health conditions.